Evidence map›Paper›PMID 23345634›Full record

ArticleNeurology2013

The THRombolysis and STatins (THRaST) study.

Manuel Cappellari, Paolo Bovi, Giuseppe Moretto, Andrea Zini, Patrizia Nencini, Maria Sessa, Mauro Furlan, Alessandro Pezzini, Giovanni Orlandi, Maurizio Paciaroni and 37 more

Abstract readMulticenter Study
In one paragraph

Article in Neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Statin, cholesterol, and sICH after acute ischemic stroke: systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019
    Pooled it
  4. Trial
  5. Article
  6. Patterns and predictors of statin therapy after ischemic stroke and TIA: insights from the LIPYDS multicenter study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Manuel CappellariSSO Stroke Unit, U.O. Neurologia d.O., DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata, Italy. manuel_cappellari@libero.it
Paolo Bovi
Giuseppe Moretto
Andrea Zini
Patrizia Nencini
Maria Sessa
Mauro Furlan
Alessandro Pezzini
Giovanni Orlandi
Maurizio Paciaroni
Tiziana Tassinari
Gaetano Procaccianti
Vincenzo Di Lazzaro
Luigi Bettoni
Carlo Gandolfo
Giorgio Silvestrelli
Maurizia Rasura
Giuseppe Martini
Maurizio Melis
Maria Vittoria Calloni
Fabio Chiodo-Grandi
Simone Beretta
Maria Guarino
Maria Concetta Altavista
Simona Marcheselli
Giampiero Galletti
Laura Adobbati
Massimo Del Sette
Armando Mancini
Daniele Orrico
Serena Monaco
Anna Cavallini
Rossella Sciolla
Francesco Federico
Umberto Scoditti
Fabio Brusaferri
Claudio Grassa
Luigi Specchio
Maria Roberta Bongioanni
Marco Sparaco
Mauro Zampolini
Gabriele Greco
Rinaldo Colombo
Bruno Passarella
Alessandro Adami
Domenico Consoli
Danilo Toni

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the impact on stroke outcome of statin use in the acute phase after IV thrombolysis.

methodsMulticenter study on prospectively collected data of 2,072 stroke patients treated with IV thrombolysis. Outcome measures of efficacy were neurologic improvement (NIH Stroke Scale [NIHSS] ≤ 4 points from baseline or NIHSS = 0) and major neurologic improvement (NIHSS ≤ 8 points from baseline or NIHSS = 0) at 7 days and favorable (modified Rankin Scale [mRS] ≤ 2) and excellent functional outcome (mRS ≤ 1) at 3 months. Outcome measures of safety were 7-day neurologic deterioration (NIHSS ≥ 4 points from baseline or death), symptomatic intracerebral hemorrhage type 2 with NIHSS ≥ 4 points from baseline or death within 36 hours, and 3-month death.

resultsAdjusted multivariate analysis showed that statin use in the acute phase was associated with neurologic improvement (odds ratio [OR] 1.68, 95% confidence interval [CI] 1.26-2.25; p < 0.001), major neurologic improvement (OR 1.43, 95% CI 1.11-1.85; p = 0.006), favorable functional outcome (OR 1.63, 95% CI 1.18-2.26; p = 0.003), and a reduced risk of neurologic deterioration (OR: 0.31, 95% CI 0.19-0.53; p < 0.001) and death (OR 0.48, 95% CI 0.28-0.82; p = 0.007).

conclusionStatin use in the acute phase of stroke after IV thrombolysis may positively influence short- and long-term outcome.

Indexed as

AgedAged, 80 and overFemaleFibrinolytic AgentsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLogistic ModelsMaleMiddle AgedMultivariate AnalysisNeurologic ExaminationOutcome Assessment, Health CareProspective StudiesRetrospective StudiesSeverity of Illness IndexStrokeFibrinolytic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsTissue Plasminogen Activator

Identifiers

PMID23345634
PMCPMC3590058

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.